Clinical trial Recruiting at 2 sites Interventional Ages 18 to 65

Comparing two surgical techniques for massive rotator cuff tears

Official title: Arthroscopic Partial Repair vs. Superior Capsular Reconstruction for Massive Irreparable Rotator Cuff Tears: A Pilot Randomized and Controlled Trial

Run by Sunnybrook Health Sciences Centre · NCT03617562 · Data updated 2026-11-12

This study is testing whether a new surgical technique called superior capsular reconstruction works better than a partial rotator cuff repair for people with large, irreparable rotator cuff tears who haven't found relief from other treatments.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment70 (estimated)
SponsorSunnybrook Health Sciences Centre
Academic / other
Locations2 sites (Toronto, Ontario and 1 other locations)
StatusRecruiting
StartedJuly 18, 2018
Main results expectedJuly 2027
Study endsJuly 2028
Registry record updatedJuly 30, 2026
Trial IDNCT03617562 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with symptomatic massive rotator cuff tears greater than 4 cm who have failed at least three months of non-surgical treatment.

Probably not a fit

Patients with advanced rotator cuff tear arthropathy, acute tears, or significant medical comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to evaluate the effectiveness of superior capsular reconstruction (SCR) versus partial rotator cuff repair (PRCR) in patients with massive irreparable rotator cuff tears. It is a randomized, controlled, double-blinded trial that will involve multiple centers and surgeons. The study will assess outcomes such as pain relief and functional improvement in patients who have not responded to non-surgical treatments. Randomization will occur intra-operatively once a tear is confirmed as irreparable, ensuring a rigorous comparison of the two surgical approaches.

Why it matters

Potential benefit: If successful, this study could provide evidence-based guidance for surgical treatment options in patients with massive rotator cuff tears.

How similar studies have gone: While SCR has shown promising results in early case series, this study is among the first to rigorously compare it with PRCR in a randomized controlled setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Symptomatic shoulder pain and/ or weakness (regardless of baseline range of motion/ psuedoparalysis)
* Massive rotator cuff tear, identified by MRI as being greater than 4 cm in greatest diameter, and involvement of the entire supraspinatus and infraspinatus.
* Failure of at least a 3 month trial of non-surgical treatment including physiotherapy and activity modifications
* Irreparable tear determined intra-operatively using standard arthroscopic techniques
* Informed consent obtained

Exclusion Criteria:

* Absence of subscapularis muscle insertion, or irreparable subscapularis tear
* Advanced rotator cuff tear arthropathy (Hamada Grade 3+) or glenohumeral osteoarthritis (Samilson-Prieto grade 2+)
* Acute tears (within 6 months)
* Neurologic injury causing paralysis of affected shoulder / arm
* Any previous surgery to the affected shoulder
* Limited life expectancy due to significant medical co-morbidity or medical contraindication to surgery (ASA Grade IV or higher)
* Anticipated problems with ability to maintain follow-up in the judgement of the investigators (ie. patients with no fixed address, etc.)
* Are there any non-orthopedic comorbidities that put the patient at significant risk?

Where it's running

  • Sunnybrook Holland Orthopaedic & Arthritic Centre
    Toronto, Ontario, Canada
    Recruiting
  • Women's College Hospital
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Long-term follow-up of FX Shoulder Solutions implants

    This follow-up will track adults who receive FX Shoulder Solutions hemi or total shoulder replacements to see if the implants need revision and how well shoulder function and pain hold up over 10 years.

    Recruiting at 22 sites FX Solutions · Amiens and 21 other locations · NCT07558590

  • Wearable-guided home rehabilitation after rotator cuff repair

    This tests whether a wearable-device remote rehabilitation program helps adults recovering from small-to-medium rotator cuff surgery regain shoulder function better than traditional in-person rehab.

    Recruiting Peking University Third Hospital · Beijing · NCT07412184

  • Rotator cuff repair using a FiberLocker patch to reinforce the tendon

    This will try a FiberLocker patch to strengthen arthroscopic rotator cuff repairs in adults aged 40–65 with traumatic full‑thickness supraspinatus (± infraspinatus) tears.

    Recruiting ZuriMED Technologies AG · Zurich, Canton of Zurich · NCT07005063

  • FiberLocker® augmentation for rotator cuff repair

    This study will test whether adding the FiberLocker® System (SpeedPatch® PET plus FiberLocker® Instrument) to arthroscopic repair improves healing and shoulder function in adults 30–70 with full-thickness rotator cuff tears of at least 2 cm.

    Recruiting at 4 sites ZuriMED Technologies Inc. · Chicago, Illinois and 3 other locations · NCT06918041

  • Using silk mesh to improve surgery for rotator cuff tears

    This study tests if using silk mesh during surgery can help older patients with rotator cuff tears heal better and prevent re-injury.

    Recruiting Phase 2/3 Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT06766630

  • Pitch-Patch Rotator Cuff Augmentation: Post-Market Follow-Up

    This study follows patients who received the Pitch-Patch to reinforce partially repairable rotator cuff tears to see how well it performs and stays safe over the long term.

    Recruiting Xiros Ltd · Reading · NCT05906004

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.